Nuveen’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-513,175
| Closed | -$20.3M | – | 3461 |
|
|
2024
Q1 | $20.3M | Buy |
513,175
+383,209
| +295% | +$11.3M | 0.01% | 1166 |
|
|
2023
Q4 | $2.48M | Buy |
129,966
+36,581
| +39% | +$508K | ﹤0.01% | 2316 |
|
|
2023
Q3 | $1.07M | Sell |
93,385
-292
| -0.3% | -$3.59K | ﹤0.01% | 2548 |
|
|
2023
Q2 | $963K | Buy |
93,677
+61,948
| +195% | +$559K | ﹤0.01% | 2680 |
|
|
2023
Q1 | $245K | Hold |
31,729
| – | – | ﹤0.01% | 2952 |
|
|
2022
Q4 | $233K | Buy |
31,729
+3,047
| +11% | +$19.5K | ﹤0.01% | 3033 |
|
|
2022
Q3 | $207K | Buy |
28,682
+10,236
| +55% | +$84.4K | ﹤0.01% | 3108 |
|
|
2022
Q2 | $157K | Hold |
18,446
| – | – | ﹤0.01% | 3172 |
|
|
2022
Q1 | $160K | Hold |
18,446
| – | – | ﹤0.01% | 3217 |
|
|
2021
Q4 | $218K | Hold |
18,446
| – | – | ﹤0.01% | 3227 |
|
|
2021
Q3 | $184K | Hold |
18,446
| – | – | ﹤0.01% | 3281 |
|
|
2021
Q2 | $166K | Buy |
+18,446
| New | +$200K | ﹤0.01% | 3262 |
|
Nuveen's ALPN Position: Q2 2024 in Review
Nuveen sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 513,175 shares — an estimated $20.3M sold.
Nuveen first reported a position in ALPN in Q2 2021 and held it in 12 quarters. The position peaked at $20.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Nuveen reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Nuveen sold 513,175 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $20.3M.
- Nuveen first reported a position in Alpine Immune Sciences Inc in Q2 2021 and held it in 12 quarters.
- Nuveen's Alpine Immune Sciences Inc position peaked at $20.3M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.